Scoat Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.00 Cr
as on 23-10-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.50 Cr
as on 23-10-2024
- Satisfied Charges ₹ 3.49 M
as on 23-10-2024
- Revenue 10.66%
(FY 2023)
- Profit 14.08%
(FY 2023)
- Ebitda 1.90%
(FY 2023)
- Net Worth 12.45%
(FY 2023)
- Total Assets -5.26%
(FY 2023)
About Scoat Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹11.50 Cr. The company has closed loans amounting to ₹3.49 M, as per Ministry of Corporate Affairs (MCA) records.
Padmaja Manepalli, Javvaji Gupta, Javvaji Aruna, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2006PTC049786
- Company No.
049786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Scoat Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmaja Manepalli  | Director | 28-Nov-2015 | Current |
| Javvaji Gupta | Director | 17-Dec-2009 | Current |
| Javvaji Aruna | Director | 06-Jan-2011 | Current |
| Kolla Swarup | Additional Director | Current |
Financial Performance of Scoat Pharma.
Scoat Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.66% increase. The company also saw a substantial improvement in profitability, with a 14.08% increase in profit. The company's net worth Soared by an impressive increase of 12.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scoat Pharma?
Unlock access to Scoat Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Boffin Pharmamed Solutions LlpActive 3 years 6 monthsJavvaji Gupta and Kolla Swarup are mutual person
- Sakksa Pharma Private LimitedActive 5 years 12 days
Javvaji Gupta and Javvaji Aruna are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Feb 2024 | ₹1.00 Cr | Open |
Others Creation Date: 14 Feb 2024 | ₹7.00 Cr | Open |
Others Creation Date: 22 Aug 2015 | ₹3.50 Cr | Open |
How Many Employees Work at Scoat Pharma?
Scoat Pharma has a workforce of 12 employees as of May 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scoat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scoat Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
